Anemia is frequent complication in hemodialysis patients. Compared to conventional
hemodialysis (CHD), short daily hemodialysis (sDHD) has been reported to be effective in
Gherian central hospital. The aim of the present study was to determine whether (sDHD) could
improve anemia and quality of life (QOL) for those patients with end-stage renal disease.
Twenty seven patients (16 males /11 females) were converted from CHD to sDHD in our study.
In this study, In Gherian Central Hospital, all patients undergoing conventional hemodialysis
(CHD) have complications including anemia and impaired quality of life (QOL). However, were
observed the (CHD) could not improve clinical outcomes in patients with End-stage renal
disease (ESRD). According to these studies (CHD) could not improve the state of anemia in
males and females N=(27), and also not increase or improvement the quality of life (QOL )
scores. However, those results were obtained from hemodialysis patients in our study under
good control and follow up in Gherian Central Hospital.
This study shows that action of conventional hemodialysis ( CHD ) was associated with
significantly difference in hemoglobin concentration by erythropoietin treatment in males and
females (P < 0.05) was considered to be significant.